Clinical Trial Finds Rectum-Preserving Treatment for Early-Stage Cancer

A landmark clinical trial published in The Lancet Oncology found that chemoradiotherapy allows four in five early-stage rectal cancer patients to avoid radical surgery.

The study recruited over 500 patients across the United Kingdom, the Netherlands, Denmark, Belgium, and Sweden to test organ-preserving treatment approaches.

Researchers are now monitoring participants for three years to confirm long-term survival rates and determine if this method can become a standard clinical option.